Search by Drug Name or NDC

    NDC 16729-0217-16 SERTRALINE HYDROCHLORIDE 100 mg/1 Details

    SERTRALINE HYDROCHLORIDE 100 mg/1

    SERTRALINE HYDROCHLORIDE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Accord Healthcare, Inc.. The primary component is SERTRALINE HYDROCHLORIDE.

    Product Information

    NDC 16729-0217
    Product ID 16729-217_0e2ed027-e131-1b40-e063-6394a90a14b5
    Associated GPIs 58160070100320
    GCN Sequence Number 046229
    GCN Sequence Number Description sertraline HCl TABLET 100 MG ORAL
    HIC3 H2S
    HIC3 Description SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS)
    GCN 16375
    HICL Sequence Number 006324
    HICL Sequence Number Description SERTRALINE HCL
    Brand/Generic Generic
    Proprietary Name SERTRALINE HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name SERTRALINE HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name SERTRALINE HYDROCHLORIDE
    Labeler Name Accord Healthcare, Inc.
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202825
    Listing Certified Through 2025-12-31

    Package

    NDC 16729-0217-16 (16729021716)

    NDC Package Code 16729-217-16
    Billing NDC 16729021716
    Package 500 TABLET, FILM COATED in 1 BOTTLE (16729-217-16)
    Marketing Start Date 2017-02-09
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.05654
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description SERTRALINE HCL 100 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis